These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 20336864
1. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Particulate Contamination: Subvisible Particles General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Jan 09; 74(6):909-10. PubMed ID: 20336864 [Abstract] [Full Text] [Related]
3. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 5 on Disintegration Test General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Dec 23; 74(245):68270-1. PubMed ID: 20344862 [Abstract] [Full Text] [Related]
4. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Jan 09; 74(6):908-9. PubMed ID: 20333832 [Abstract] [Full Text] [Related]
5. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial texts for use in the International Conference on Harmonisation Regions; Annex 12 on Analytical Sieving General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2010 Sep 02; 75(170):53873-4. PubMed ID: 20812423 [Abstract] [Full Text] [Related]
6. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 7 on Dissolution Test General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2010 Apr 05; 75(64):17148-9. PubMed ID: 20383923 [Abstract] [Full Text] [Related]
7. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Apr 08; 74(66):15992-3. PubMed ID: 19507323 [Abstract] [Full Text] [Related]
8. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 9 on Tablet Friability General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2010 Apr 05; 75(64):17147-8. PubMed ID: 20383922 [Abstract] [Full Text] [Related]
9. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4B on Microbiological Examination of nonsterile products: Tests for Specified Microorganisms General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Apr 08; 74(66):15989-90. PubMed ID: 19507320 [Abstract] [Full Text] [Related]
10. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4A on Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Apr 08; 74(66):15991-2. PubMed ID: 19507322 [Abstract] [Full Text] [Related]
11. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 14 on Bacterial Endotoxins Test General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2013 Oct 23; 78(205):63221-2. PubMed ID: 24156134 [Abstract] [Full Text] [Related]
12. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 10 on Polyacrylamide Gel Electrophoresis General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2010 Apr 12; 75(69):18509-10. PubMed ID: 20387318 [Abstract] [Full Text] [Related]
13. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 13 on Bulk Density and Tapped Density of Powders General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2013 May 28; 78(102):31944-5. PubMed ID: 23724425 [Abstract] [Full Text] [Related]
14. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 6 on Uniformity of Dosage Units General Chapter; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2014 Jun 16; 79(115):34314-5. PubMed ID: 25011159 [Abstract] [Full Text] [Related]
15. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex on Residue on Ignition/Sulphated Ash General Chapter; Availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2008 Feb 21; 73(35):9576-7. PubMed ID: 18677820 [Abstract] [Full Text] [Related]
16. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2008 Feb 21; 73(35):9575-6. PubMed ID: 18677819 [Abstract] [Full Text] [Related]
17. International Conference on Harmonisation; draft guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Disintegration Test General Chapter; availability. Notice. Fed Regist; 2008 Aug 05; 73(151):45466-7. PubMed ID: 18956490 [No Abstract] [Full Text] [Related]
18. International Conference on Harmonisation; guidance on Q8(R1) Pharmaceutical Development; addition of annex; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Jun 09; 74(109):27325-6. PubMed ID: 19588572 [Abstract] [Full Text] [Related]
19. International Conference on Harmonisation: guidance on Q1D bracketing and matrixing designs for stability testing of new drug substances and products; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2003 Jan 16; 68(11):2339-40. PubMed ID: 12532979 [Abstract] [Full Text] [Related]
20. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2003 Feb 11; 68(28):6924-5. PubMed ID: 12583358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]